Clinical Trial Update: Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating RIVAstigmine for motor, cognitive, and behavioral impairment in progressive supranuclear palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Progressive Supranuclear Palsy (PSP) | Phase 3 | Status: COMPLETED